---
figid: PMC9701058__13062_2022_348_Fig11_HTML
pmcid: PMC9701058
image_filename: 13062_2022_348_Fig11_HTML.jpg
figure_link: /pmc/articles/PMC9701058/figure/Fig11/
number: Fig. 11
figure_title: ''
caption: C646 treatment inhibited MC38CXCL1+/+ colon cancer tumor progression. a Experimental
  protocol for measuring the effect of C646 treatment in subcutaneous graft colon
  cancer models. b–d Tumor growth curve after treatment with C646 (MC38 WT, MC38CXCL1−/−,
  MC38CXCL1+/+). Administered by intraperitoneal injection every three days. Each
  data point is the mean ± SD (n = 5). **P < 0.01, ****P < 0.0001
article_title: CXCL1 promotes colon cancer progression through activation of NF-κB/P300
  signaling pathway.
citation: Changhua Zhuo, et al. Biol Direct. 2022;17:34.
year: '2022'

doi: 10.1186/s13062-022-00348-4
journal_title: Biology Direct
journal_nlm_ta: Biol Direct
publisher_name: BioMed Central

keywords:
- CXCL1
- Colon cancer
- NF-κB
- P300
- C646

---
